Life-Saving Partnership: PCFA and ANZUP Announce Joint Prostate Cancer Fight
MEDIA RELEASE
Life-saving partnership: PCFA and ANZUP announce joint prostate cancer fight
- Partnership will facilitate clinical trials
- $1.5 million fundraising goal
1 March 2016: A powerful new partnership was announced today by two key players in the fight against prostate cancer. ANZUP Cancer Trials Group Limited (ANZUP), the leading collaborative trials group for urogenital and prostate cancer, and Prostate Cancer Foundation of Australia (PCFA), the peak national body for prostate cancer, will work together to fund and implement vital clinical trials in prostate cancer.
ANZUP and PCFA have signed a formal agreement to improve access to clinical trials and have pledged to work together to raise $1.5 million over the next three years to fund trials.
Margaret McJannett, CEO,ANZUP Cancer Trials Group says the formal partnership is an exciting next step for the two organisations. “We have worked closely with PCFA for many years and this formal partnership is the logical next step for clinical trials in prostate cancer” she said.
PCFA CEO, A/Prof Anthony Lowe commented “Learning how to make better use of existing treatments and knowledge is equally important to new basic science research. That’s what clinical trials are all about”. “ANZUP is the leading collaborative trials group for prostate cancer in Australia and New Zealand so they are best placed to help us achieve this goal.”
Ms McJannett added “Clinical trials are the gold standard for developing new cancer treatments and showing which treatments are the safest and most effective. Trials independent of drug companies are particularly valuable, as they focus only on patient benefit with no commercial stake.” “For Australia’s peak prostate cancer charity to team up with the leading independent provider of clinical trials in Australia and New Zealand opens up a range of opportunities in clinical research,” she said.
Under the partnership PCFA will continue to be a Platinum Sponsor of the ANZUP Annual Scientific Meeting and PCFA’s annual Prostate Cancer Specialist Nursing Service conference will be held in conjunction with the ASM.
ENDS
For all media enquiries, please contact Zoe Adler Bishop (, 04244 627 22) or Maya Ivanovic (, 0403 354 305) at Palin Communications on 02 9412 2255
ABOUT ANZUP Cancer Trials Group Limited
ANZUP’s mission is to conduct clinical trial research to improve treatment of Bladder, Kidney, Testicular and Prostate Cancers.
The objectives of the Company are to develop, foster and promote prostate and urogenital cancer research by:
- providing access to clinical trials for all appropriate Australian and New Zealand patients
- increasing involvement of and collaboration with various professional disciplines in clinical and preclinical research
- providing opportunities for clinical research
- building systems to simplify and streamline clinical research of the highest quality
- fostering a culture of research amongst all clinicians involved in the care of patients with urogenital cancers
- providing training opportunities for the next generation of clinical researchers
- providing for translational studies in prostate and other urogenital cancers, including tissue banking from clinical trials for further studies
ABOUT PROSTATE CANCER FOUNDATION OF AUSTRALIA
Prostate Cancer Foundation of Australia (PCFA) is a broad-based community organisation and the peak national body for prostate cancer in Australia. We are dedicated to reducing the impact of prostate cancer on Australian men, their partners and families, recognising the diversity of the Australian community.
We do this by:
- Promoting and funding world leading, innovative research into prostate cancer
- Implementing awareness campaigns and education programs for the Australian community, health professionals and Government
- Supporting men and their families affected by prostate cancer through evidence-based information and resources, support groups and Prostate Cancer Specialist Nurses
PCFA relies on the generosity of individuals, the community and partnerships to carry out our essential work.